Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase

No abstract is available for this paper.

• Publication year

  1975

• Venue

  Nature

• Publication date

  1975-10-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/257700A0PMID 241939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation.

  1975cited by this paper
• Localization of particulate guanylate cyclase in plasma membranes and microsomes of rat liver.

  1975cited by this paper
• Effects of decapitation, ether and pentobarbital on guanosine 3',5'-phosphate and adenosine 3',5'-phosphate levels in rat tissues.

  1974cited by this paper
• Cyclic nucleotide levels in incubations of guinea pig trachea.

  1974cited by this paper
• Nonenzymatic formation of guanosine 3':5'-monophosphate from guanosine triphosphate.

  1974cited by this paper
• Evidence for two different forms of guanylate cyclase in rat heart.

  1974cited by this paper
• Cyclic GMP.

  1973cited by this paper
• The importance of calcium ions for the regulation of guanosine 3':5'-cyclic monophosphage levels.

  1973cited by this paper
• Cerebellar cortical degeneration due to acute azide poisoning.

  1972cited by this paper
• Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

  1972cited by this paper
• Experimental striatal necrosis induced by sodium azide

  1967cited by this paper
• Studies on azide, caeruloplasmin and copper in relation to Wilson's disease.

  1967cited by this paper
• Elevation of gamma-aminobutyric acid in brain: selective inhibition of gamma-aminobutyric-alpha-ketoglutaric acid transaminase.

  1961cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Actions of sodium azide.

  1949cited by this paper
• A REVIEW OF SOME RECENT OBSERVATIONS ON DEMYELINATION

  1944cited by this paper

• Soluble Guanylate Cyclase Modulators and Inhibitors for Neurological Disorders

  2016cites this paper
• What is next in nitric oxide research? From cardiovascular system to cancer biology.

  2014cites this paper
• Molecular model of soluble guanylyl cyclase: Insight into allostery in nitric oxide signaling

  2011cites this paper
• Nitric oxide: a short lived molecule stays alive.

  2010cites this paper
• Hydroxylamines and Oximes: Biological Properties and Potential Uses as Therapeutic Agents

  2010cites this paper
• The emerging role of nitrite as an endogenous modulator and therapeutic agent of cardiovascular function.

  2010cites this paper
• A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases.

  2009cites this paper
• Actions of 1,1,1-trichloroethane on the cAMP metabolism in mouse brain.

  2009cites this paper
• Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.

  2008cites this paper
• Hyperpolarisation-activated ion channels as a target for nitric oxide-cGMP signalling in the rat brain

  2008cites this paper
• Nitric oxide signaling comes of age: 20 years and thriving.

  2007cites this paper
• Regulatory role and evolution of unconventional NOS-related RNAs

  2007cites this paper
• A Brief History of Great Discoveries in Pharmacology: In Celebration of the Centennial Anniversary of the Founding of the American Society of Pharmacology and Experimental Therapeutics

  2007cites this paper
• Nitric Oxide and Cyclic GMP in Cell Signaling and Drug Development

  2006cites this paper
• Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development.

  2006cites this paper
• Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling

  2005cites this paper
• Ferid Murad, MD, PhD: a conversation with the editor.

  2004cites this paper
• The excitement and rewards of research with our discovery of some of the biological effects of nitric oxide.

  2003cites this paper
• Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG.

  2003cites this paper
• Paracrine neuroprotective effect of nitric oxide in the developing retina

  2001cites this paper
• Cellular signaling with nitric oxide and cyclic guanosine monophosphate.

  2000cites this paper
• Nitric oxide leads to prized NObility: background to the work of Ferid Murad.

  1999cites this paper
• Die Entdeckung einiger biologischer Wirkungen von Stickstoffmonoxid und seiner Rolle für die Zellkommunikation (Nobel‐Vortrag)

  1999cites this paper
• Cellular signaling with nitric oxide and cyclic GMP.

  1999influential citation
• Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling

  1999cites this paper
• Hydroxylamine blocks adenosine A1 receptor-mediated inhibition of synaptic transmission in rat hippocampus.

  1999cites this paper
• Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling

  1999influential citation
• Hydroxylamine blocks pre- but not postsynaptic adenosine A(1) receptor-mediated actions in rat hippocampus.

  1999cites this paper
• Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone?

  1998cites this paper
• The generation of nitric oxide by G protein-coupled receptors.

  1998cites this paper
• What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle?

  1997cites this paper
• Signal Transduction Using Nitric Oxide and Cyclic Guanosine Monophosphate

  1996cites this paper
• The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate.

  1996cites this paper
• Bioactivation of Organic Nitrates and Other Nitrovasodilators

  1996cites this paper
• Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues.

  1995cites this paper
• The Nitric Oxide Signal Transduction System

  1995cites this paper
• Oxygen-radical/nitric oxide mediate calcium-dependent hormone action on cyclic GMP system: A novel concept in signal transduction mechanisms

  1995cites this paper
• Effects of cyclic GMP on smooth muscle relaxation.

  1994cites this paper
• The actions of nitrovasodilators on spontaneously active smooth muscle

  1994cites this paper
• The family of guanylyl cyclase receptors and their ligands.

  1994cites this paper
• Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.

  1994cites this paper
• The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication.

  1994cites this paper
• Regulation of cytosolic guanylyl cyclase by porphyrins and metalloporphyrins.

  1994cites this paper
• CHAPTER 5 – GUANYLYL CYCLASE-LINKED RECEPTORS

  1993cites this paper
• Isoforms of Nitric Oxide Synthase and the Nitric Oxide-Cyclic Gmp Signal Transduction System

  1993cites this paper
• The nitric oxide-cyclic GMP signal transduction pathway in vascular smooth muscle preparations and other tissues.

  1992cites this paper
• Guanylyl cyclase-linked receptors.

  1992cites this paper
• Low concentrations of sodium azide specifically inhibit a thromboxane A2 pathway in human platelets.

  1992cites this paper
• Guanylyl cyclase-linked receptors.

  1991cites this paper
• Glutamate Receptors, Nitric Oxide, and Cyclic GMP

  1991cites this paper
• Effect of age on rabbit aortic responses to relaxant endothelium-dependent and endothelium-independent agents.

  1991cites this paper
• Sarcolemmal (Ca2(+)+Mg2+)-ATPase of vascular smooth muscle and the effects of protein kinases thereupon.

  1990cites this paper
• Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.

  1989cites this paper
• Electron microscopical localization of guanylate cyclase activity in the neocortex of the guinea pig.

  1989cites this paper
• Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.

  1989cites this paper
• Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxide.

  1989cites this paper
• Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein

  1989cites this paper
• Nitroglycerin relaxes canine coronary arterial smooth muscle without reducing intracellular Ca2+ concentrations measured with fura‐2

  1989cites this paper
• Histochemistry of nucleotidyl cyclases and cyclic nucleotide phosphodiesterases

  1988cites this paper
• Effects of nitrovasodilators, endothelium-dependent vasodilators, and atrial peptides on cGMP.

  1988cites this paper
• Effect of nipradilol, a new beta-blocker, on leukotriene D4-induced contraction in guinea pig tracheal smooth muscle.

  1988cites this paper
• Defective cyclic GMP accumulation in spontaneously hypertensive rat aorta in response to atrial natriuretic factor.

  1988cites this paper
• Cyclic GMP synthesis and function.

  1987cites this paper
• Effects of 1,1,1-trichloroethane on the cGMP metabolism in mouse brain.

  1986cites this paper
• Cyclic guanosine monophosphate as a mediator of vasodilation.

  1986cites this paper
• Attempts for light microscopical demonstration of guanylate cyclase activity in rat cerebellum.

  1986cites this paper
• N-methyl-N'-nitro-N-nitrosoguanidine and cyclic GMP stimulate phosphorylation of nuclear proteins from rat liver.

  1986cites this paper
• Lithium ions inhibit function of lowbut not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115)

  1985cites this paper
• The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation.

  1985cites this paper
• Negative regulation of cyclic-AMP levels by carbamylcholine in dog thyroid is not mediated by cyclic-GMP.

  1985cites this paper
• Role of cyclic‐GMP in Relaxations of Vascular mooth Muscle

  1985cites this paper
• Molecular Mechanisms of Vasodilatation

  1984cites this paper
• Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.

  1984cites this paper
• [Cyclic GMP: its biosynthesis and physiological role].

  1984cites this paper
• Enrichment of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in cholinergic axon terminals of the Torpedo electric organ.

  1983cites this paper
• Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.

  1983cites this paper
• Effect of some beta-adrenergic blocking agents on tissue guanylate cyclase and cyclic nucleotides in the rat.

  1983cites this paper
• Effects of psychoactive drugs on cyclic nucleotides in the central nervous system.

  1983cites this paper
• Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation.

  1983cites this paper
• Activation of purified soluble guanylate cyclase by protoporphyrin IX.

  1982cites this paper
• Guanylate Cyclase: Regulation of Cyclic GMP Metabolism

  1982cites this paper
• Cyclic Nucleotides and Fever

  1982cites this paper
• The Role of Cyclic Nucleotide Metabolism in the Eye

  1982cites this paper
• Adenylate cyclase responses in rat brain after unilateral postnatal X-irradiation.

  1982cites this paper
• Role of Phospholipid in the Transmitter-Induced Synthesis of Cyclic GMP in Nervous Tissue

  1982cites this paper
• Effect of benzodiazepines on cyclic GMP formation in rat cerebellar slices.

  1982cites this paper
• Distribution of guanylate cyclase in rat cerebral cortex: neuronal, glial, capillary, pia-arachnoid and synaptosomal fractions plus choroid plexus.

  1981cites this paper
• Activation of hepatic guanylate cyclase by nitrosyl-heme complexes. Comparison of unpurified and partially purified enzyme.

  1981cites this paper
• Effects of pyruvate and other metabolites on cyclic GMP levels in incubations of rat hepatocytes and kidney cortex.

  1981cites this paper
• Actions of chlorpromazine metabolites on brain guanylate cyclase.

  1981cites this paper
• Evidence for guanylate cyclase activity associated with hemagglutinating virus of Japan (Sendai virus).

  1981cites this paper
• Guanylate cyclase: purification, properties, free radical activation, radiolabeling, and preparation of hybridoma antibodies.

  1981cites this paper
• Distribution and different activation of adenylate cyclase by NaF and of guanylate cyclase by NaN3 in neuronal and glial cells separated from rat cerebral cortex.

  1981cites this paper
• The Effects of Kainic Acid Injections on Guanylate Cyclase Activity in the Rat Caudatoputamen, Nucleus Accumbens and Septum

  1981cites this paper
• Cyclic guanosine 3':5'-monophosphate accumulation and 45Ca-uptake by rat superior cervical ganglia during preganglionic stimulation.

  1981cites this paper
• Guanylate cyclase--cyclic GMP in mouse cerebral cortex and cerebellum: modification by anticonvulsants.

  1981cites this paper
• Selective alterations in responsiveness of guanylate cyclase to activation by nitroso compounds during enzyme purification.

  1981cites this paper
• Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

  1981cites this paper
• Does endogenous cyclic GMP inhibit potassium stimulated 45Ca uptake by P2 fraction from rat brain?

  1981cites this paper
• Divalent Cations and Regulation of Cyclic Nucleotides in Nervous Systems

  1981cites this paper